ghrp-2 and igf-1 lr3 stack vs GH Peptides Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Rossignol D.A., Frye R.E
Phase II trials showed reduced injury markers during surgery (Orhan et al., 2006) and, notably, a significant reduction in infarct size and improved myocardial salvage when combined with nitrates in acute STEMI patients undergoing primary PCI [NACIAM trial (Pasupathy et al., 2017)], suggesting potential utility in the acute setting, possibly by enhancing endogenous defenses
PMID: 38611056
Schwartzhoff Durward A
doi: 10.1016/j.chembiol.2008.02.010 13 KhareASamudre S and AroraA
